BYTE (BYTE) fluctuates 100.0% in 24 hours: Low liquidity meme coins on the ETH chain rebound with no apparent event driver
Bitget Pulse2026/03/18 22:03Volatility Overview
In the past 24 hours, BYTE's price rebounded from a low of $0.000020 to a high of $0.000040, currently at $0.000030, with a fluctuation amplitude reaching 100.0%. This token is an ETH chain meme coin with low liquidity, which amplifies volatility. There was no significant abnormal expansion in 24-hour trading volume data.
Brief Analysis of Abnormal Movement Causes
- Low liquidity driving the rebound: The ETH chain meme coin characteristic leads to sharp price swings from small trades, without needing large capital to move the market.
- No official events or whale activities: On-chain monitoring did not show signs of large holders buying/selling, nor were there announcements or news catalysts.
- Temporary community engagement on X: Some discussions mentioned the price rebound, but no sustained hype was formed.
Market Views and Outlook
The mainstream market sentiment is cautious. Bitget’s analysis highlights the risks of low liquidity and reminds investors of the sharp volatility caused by small trades. The short-term rebound may be technical and lacks ongoing momentum; most community opinions consider it a typical “no news pump” for meme coins, making a pullback likely. High-risk operations are advised against.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
RBA set to hike interest rate to 4.60% in September as inflation remains elevated
AstraZeneca invests $2 billion in Summit, optimistic about Akeso's Ivose
This 18.6% premium subscription is not only a substantial endorsement, but both parties will also deeply collaborate on the joint development of combination therapies such as ADCs. The core of this deal is Akeso's Ivonescimab—the world’s first PD-1/VEGF bispecific antibody, and so far the only drug to have surpassed "K-drug" in head-to-head trials on both PFS and OS endpoints. The median OS reached 30.8 months, compared to 22.6 months for "K-drug", representing a 27% reduction in risk of death.
AMD (AMD.US) Surpasses $1 Trillion Market Cap and Begins Competing for "Computing Power Definition Rights"! Officially Announces $8.2 Billion Acquisition of Fei-Fei Li's World Labs
AMD has agreed to acquire World Labs for $8.2 billion, thereby gaining access to the artificial intelligence startup founded by industry pioneer and researcher Fei-Fei Li. This acquisition is expected to help AMD plan its future hardware launches by bringing in a team of top researchers and their models, as well as deep insights into trends in the field of artificial intelligence.
Crypto prices
More
